215 related articles for article (PubMed ID: 11037619)
1. [Immuno-intervention in cutaneous lymphomas].
Dummer R; Heinzerling L; Schmid MH; Burg G
Praxis (Bern 1994); 2000 Sep; 89(37):1471-6. PubMed ID: 11037619
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
3. New and experimental skin-directed therapies for cutaneous lymphomas.
Farkas A; Kemeny L; French LE; Dummer R
Skin Pharmacol Physiol; 2009; 22(6):322-34. PubMed ID: 19786826
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in cutaneous lymphomas.
Dummer R; Asagoe K; Cozzio A; Burg G; Doebbeling U; Golling P; Fujii K; Urosevic M
J Dermatol Sci; 2007 Dec; 48(3):157-67. PubMed ID: 17964121
[TBL] [Abstract][Full Text] [Related]
5. Primary cutaneous B-cell lymphoma: classification and treatment.
Willemze R
Curr Opin Oncol; 2006 Sep; 18(5):425-31. PubMed ID: 16894288
[TBL] [Abstract][Full Text] [Related]
6. The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants.
Slater DN
Br J Dermatol; 2005 Nov; 153(5):874-80. PubMed ID: 16225594
[TBL] [Abstract][Full Text] [Related]
7. Monitoring the decrease of circulating malignant T cells in cutaneous T-cell lymphoma during photopheresis and interferon therapy.
Ferenczi K; Yawalkar N; Jones D; Kupper TS
Arch Dermatol; 2003 Jul; 139(7):909-13. PubMed ID: 12873887
[TBL] [Abstract][Full Text] [Related]
8. Standard and experimental therapy in cutaneous T-cell lymphomas.
Dummer R; Cozzio A; Meier S; Beyeler M; Laetsch B; Doebbeling U; Urosevic M
J Cutan Pathol; 2006 Feb; 33 Suppl 1():52-7. PubMed ID: 16412213
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II.
Paulli M; Berti E
Haematologica; 2004 Nov; 89(11):1372-88. PubMed ID: 15531460
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulators in the treatment of cutaneous lymphomas.
Dummer R
Expert Opin Biol Ther; 2002 Mar; 2(3):279-86. PubMed ID: 11890867
[TBL] [Abstract][Full Text] [Related]
11. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
[TBL] [Abstract][Full Text] [Related]
12. [New aspects in the classification of cutaneous lymphomas].
Erós N; Károlyi Z; Kovács A
Orv Hetil; 2001 Feb; 142(8):393-8. PubMed ID: 11263077
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates.
Magro CM; Dyrsen ME
J Cutan Pathol; 2008 Nov; 35(11):1040-9. PubMed ID: 18681860
[TBL] [Abstract][Full Text] [Related]
14. Post-transplant cutaneous T-cell lymphomas.
Lok C; Viseux V; Denoeux JP; Bagot M
Crit Rev Oncol Hematol; 2005 Oct; 56(1):137-45. PubMed ID: 16046144
[TBL] [Abstract][Full Text] [Related]
15. [Prognosis of primary cutaneous lymphomas].
Grange F; Bagot M
Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):30-40. PubMed ID: 11937927
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous T-cell lymphomas: a review with emphasis on new treatment approaches.
Querfeld C; Rosen ST; Kuzel TM; Guitart J
Semin Cutan Med Surg; 2003 Sep; 22(3):150-61. PubMed ID: 14649582
[TBL] [Abstract][Full Text] [Related]
17. Advances in understanding the immunobiology and immunotherapy of cutaneous T-cell lymphoma.
Berger CL; Mariwalla K; Girardi M; Edelson RL
Adv Dermatol; 2004; 20():217-35. PubMed ID: 15544202
[No Abstract] [Full Text] [Related]
18. Complete remission of a primary cutaneous B-cell lymphoma of the lower leg by first-line monotherapy with the CD20-antibody rituximab.
Bonnekoh B; Schulz M; Franke I; Gollnick H
J Cancer Res Clin Oncol; 2002 Mar; 128(3):161-6. PubMed ID: 11935303
[TBL] [Abstract][Full Text] [Related]
19. Expression of the CD1a molecule in B- and T-lymphoproliferative skin conditions.
Pigozzi B; Bordignon M; Belloni Fortina A; Michelotto G; Alaibac M
Oncol Rep; 2006 Feb; 15(2):347-51. PubMed ID: 16391853
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of cutaneous lymphomas.
Breneman DL
Compr Ther; 1996 Mar; 22(3):169-74. PubMed ID: 8706387
[No Abstract] [Full Text] [Related]
[Next] [New Search]
